From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

For decades, Parkinson’s disease has been diagnosed only after unmistakable symptoms such as tremor, stiffness, and slowed ...

Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of mid- to late-stage Parkinson disease in adults. In combination with levodopa alone or ...

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson ...

According to recent data from medical records, Nebraska and Kansas have the highest rates of Parkinson’s disease diagnoses.

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...